Are two emergency department visits for asthma in the past year a risk factor for asthma-related death?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Having two emergency department visits for asthma in the past year is not explicitly listed as a risk factor for asthma-related death in the most recent and highest quality study available, which instead notes three or more ED visits in the past year as a risk factor 1. However, it is essential to consider the context and the overall clinical picture. The guidelines suggest that patients with a history of frequent emergency department visits for asthma should be evaluated for poorly controlled asthma and managed accordingly.

  • Key points to consider in managing such patients include:
    • Prompt referral to an asthma specialist
    • Optimization of controller medications, such as inhaled corticosteroids and long-acting beta-agonists
    • Development of a detailed asthma action plan
    • Close follow-up and education about early recognition of worsening symptoms The underlying reason for the increased mortality risk in patients with frequent asthma exacerbations is the potential for airway remodeling, progressive loss of lung function, and fatal respiratory failure during subsequent attacks, as well as the persistence of airway inflammation due to inadequate controller therapy 1.
  • Risk factors for asthma-related death, as outlined in the guidelines, include:
    • Previous severe exacerbation
    • Two or more hospitalizations or more than three ED visits in the past year
    • Use of more than two canisters of short-acting beta-2 agonist per month
    • Difficulty perceiving airway obstruction or the severity of worsening asthma
    • Low socioeconomic status or inner-city residence
    • Illicit drug use
    • Major psychosocial problems or psychiatric disease
    • Comorbidities, such as cardiovascular disease or other chronic lung disease 1.

From the Research

Asthma-Related Death Risk Factors

  • Two emergency department visits for asthma in the past year may indicate a higher risk of asthma-related complications, but the provided studies do not directly address the risk of asthma-related death associated with this specific frequency of visits.
  • A study from 1995 2 found that patients with multiple emergency department visits for asthma in the past year had more severe asthma, were more likely to have nocturnal asthma, and had higher rates of work and school absenteeism.
  • Another study from 2014 3 characterized patients with asthma according to their frequency of ED visits and found that frequent ED users had suboptimal guideline-recommended management, including lack of evidence of prior evaluation by an asthma specialist and inadequate treatment with inhaled corticosteroids.

Emergency Department Visits and Asthma Severity

  • The 1995 study 2 suggested that multiple emergency department visits are associated with increased asthma severity, as indicated by the need for hospital admission and the presence of nocturnal asthma.
  • The 2014 study 3 also found that markers of chronic asthma severity were significant predictors of frequent ED visits.
  • However, none of the provided studies directly link two emergency department visits for asthma in the past year to an increased risk of asthma-related death.

Asthma Management and Outcomes

  • Studies from 2009 4 and 2012 5 demonstrated the effectiveness of combination therapies, such as salmeterol/fluticasone propionate, in improving asthma outcomes and reducing the risk of severe exacerbations.
  • The 2005 review 6 of inhaled salmeterol/fluticasone propionate also highlighted its effectiveness in maintaining asthma control and improving lung function and symptoms.
  • While these studies provide insight into effective asthma management strategies, they do not specifically address the risk of asthma-related death associated with two emergency department visits in the past year.

Related Questions

Alternative to Advair (Fluticasone-Salmeterol) inhaler?
What is the next line of management for a 62-year-old female with bronchial asthma (BA) and a mouth polyp versus ulcer, who has partial relief from breathlessness with nebulization and oral pain with betadine (povidone-iodine) mouth gargle?
What is the best way to minimize the risk of an asthma exacerbation in a patient with poor adherence to fluticasone-salmeterol therapy and difficulty refilling albuterol?
Is Advair (fluticasone/salmeterol) 50/100 suitable for a 13-year-old patient with poorly controlled asthma, experiencing shortness of breath (SOB) during normal activities, despite no nocturnal symptoms for 2 weeks?
A 20-year-old female with a history of asthma, currently using albuterol (a bronchodilator) daily, is seeking a non-powdered inhaler to control symptoms of daily tight breathing, as the powdered form is exacerbating her breathing difficulties.
Can tranexamic acid (TXA) stop a gastrointestinal (GI) bleed?
What is the recommended wound care for a patient with large scabbing after suture removal?
What is the next step for volume resuscitation in a hypotensive (low blood pressure) pediatric patient with tachycardia (elevated heart rate) and abdominal tenderness after initial fluid bolus?
Is the use of more than 1 metered-dose inhaler (MDI) of a short-acting beta-agonist (SABA) per month a risk factor for asthma-related death?
What are the clinical manifestations, diagnostic methods, and management strategies for alpha-1 antitrypsin deficiency?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.